FDA Inspection 1091241 — Bingbing Pharmaceutical (Hubei) Co., Ltd
The FDA completed an inspection of Bingbing Pharmaceutical (Hubei) Co., Ltd on May 10, 2019 in Shiyan. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- May 10, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shiyan (China)